Literature DB >> 15060982

Exploitation of host cell cytoskeleton and signalling during Listeria monocytogenes entry into mammalian cells.

Javier Pizarro-Cerdá1, Sandra Sousa, Pascale Cossart.   

Abstract

Deciphering how Listeria monocytogenes exploits the host cell machinery to invade mammalian cells during infection is a key issue for the understanding how this food-borne pathogen causes a pleiotropic disease ranging from gastro-enteritis to meningitis and abortions. Using multidisciplinary approaches, essentially combining bacterial genetics and cell biology, we have identified two bacterial proteins critical for entry into target cells, InlA and InlB. Their cellular ligands have been also identified: InlA interacts with the adhesion molecule E-cadherin, while InlB interacts with the receptor for the globular head of the complement factor C1q (gC1q-R), with the hepatocyte growth factor receptor (c-Met) and with glycosaminoglycans (including heparan sulphate). The dynamic interaction between these cellular receptors and the actin cytoskeleton is currently under investigation. Several intracellular molecules have been recognized as key effectors for Listeria entry into target cells, including catenins (implicated in the connection of E-cadherin to actin) and the actin depolymerising factor/cofilin (involved in the rearrangement of the cytoskeleton in the InlB-dependent internalisation pathway). At the organism level, species specificity has been discovered concerning the interaction between InlA and E-cadherin, leading to the generation of transgenic mice expressing the human E-cadherin, in which the critical role of InlA in the crossing of the intestinal barrier has been clearly determined. Listeria appears as an instrumental model for addressing critical questions concerning both the complex process of bacterial pathogenesis and also fundamental molecular processes, such as phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060982     DOI: 10.1016/j.crvi.2003.11.007

Source DB:  PubMed          Journal:  C R Biol        ISSN: 1631-0691            Impact factor:   1.583


  7 in total

Review 1.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

2.  Differential inlA and inlB expression and interaction with human intestinal and liver cells by Listeria monocytogenes strains of different origins.

Authors:  Hadewig Werbrouck; Koen Grijspeerdt; Nadine Botteldoorn; Els Van Pamel; Nancy Rijpens; Jo Van Damme; Mieke Uyttendaele; Lieve Herman; Els Van Coillie
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

Review 3.  Beyond good and evil in the oral cavity: insights into host-microbe relationships derived from transcriptional profiling of gingival cells.

Authors:  M Handfield; H V Baker; R J Lamont
Journal:  J Dent Res       Date:  2008-03       Impact factor: 6.116

4.  The human fungal pathogen Cryptococcus neoformans escapes macrophages by a phagosome emptying mechanism that is inhibited by Arp2/3 complex-mediated actin polymerisation.

Authors:  Simon A Johnston; Robin C May
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

5.  The contribution of gC1qR/p33 in infection and inflammation.

Authors:  Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Immunobiology       Date:  2007-01-03       Impact factor: 3.144

Review 6.  Bacterial subversion of host actin dynamics at the plasma membrane.

Authors:  Rey Carabeo
Journal:  Cell Microbiol       Date:  2011-08-31       Impact factor: 3.715

7.  Role of lipid rafts in E-cadherin-- and HGF-R/Met--mediated entry of Listeria monocytogenes into host cells.

Authors:  Stéphanie Seveau; Hélène Bierne; Stéphanie Giroux; Marie-Christine Prévost; Pascale Cossart
Journal:  J Cell Biol       Date:  2004-08-30       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.